POZ - News : Mathematical Model Maps Out Drug-Resistant HIV in San Francisco
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » News » February 2008

Web Exclusives

Evaluating the Costs of Earlier HIV Treatment

HIV Prevention Gets “Fergalicious”

Changing the HIV Treatment Paradigm

» More

Most Talked About

Magic Johnson Accused of Faking HIV (41)

The POZ/DDF Ratio (blog) (30)

Guidelines Prediction: Start Treatment Earlier (blog) (16)

HIV-Positive People Living Longer Than Ever Before (14)

Bone Marrow Transplant: Potential AIDS Cure? (8)

Obama Campaign Set to Boost Domestic HIV/AIDS Funding (8)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

10 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

February 20, 2008

Mathematical Model Maps Out Drug-Resistant HIV in San Francisco

A mathematical model unveiled by the University of California, Los Angeles AIDS Institute shows that drug-resistant strains of HIV will continue to impact San Francisco’s men who have sex with men (MSM) population over the next five years, ScienceDaily reports (sciencedaily.com, 2/17). However, this model also found that drug-resistant HIV may have made the city’s epidemic less severe by lowering its rate of new infections.
 
The mathematical model—called the Amplification Cascade Model—showed that while strains of HIV with dual- and triple-class resistance will increase, they will be less infectious than “wild-type” strains of the virus, strains that remain sensitive to all drug classes.

Study author and UCLA biomathematics professor Sally Blower told ScienceDaily, “Our Amplification Cascade Model has been validated by our reconstructions and can now be used to design novel and effective health policies for controlling single-, dual- and triple-class resistant strains of HIV in both resource-rich and resource-constrained countries.”
 


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

keith, rochester, 2008-02-24 19:34:03
any model that just includes men with men sex is a bad model. you have just jumped back 26yrs. to grids how sad

Jack, San Francisco, 2008-02-21 15:37:49
It is very disturbing for anyone to create a "model" to predict the future, then not mention any actual data to back that up. Not even a margin of error? Are they saying it is flawless? Until such time as someone else reconstructs and validates the model, using it to design public health policies seems to be an alarmingly bad idea.

comments 1 - 2 (of 2 total)    


[Go to top]


Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Would legalizing prostitution reduce the spread of HIV?
Yes
No
I don't know.

Monthly Poll
Question: Do you believe that prisoners receive adequate health care?
Yes
No
I don't know.

Surveys
Tell us when and to whom you disclose your status.

Tell us about your travel experiences.

more surveys
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy